Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer.

Guitart X, Navarro G, Moreno E, Yano H, Cai NS, Sánchez-Soto M, Kumar-Barodia S, Naidu YT, Mallol J, Cortés A, Lluís C, Canela EI, Casadó V, McCormick PJ, Ferré S.

Mol Pharmacol. 2014 Oct;86(4):417-29. doi: 10.1124/mol.114.093096. Epub 2014 Aug 5.

2.

Decadal status of a major 'industrial belt' on the local groundwaters: a case study in Visakhapatnam (India).

Naidu YS, Subbarao C, Prasad N, Prasad PR.

J Environ Sci Eng. 2010 Jul;52(3):245-54.

PMID:
21391399
3.

Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson's disease compared to conventional therapy: a real life study of non motor effect.

Martinez-Martin P, Reddy P, Antonini A, Henriksen T, Katzenschlager R, Odin P, Todorova A, Naidu Y, Tluk S, Chandiramani C, Martin A, Chaudhuri KR.

J Parkinsons Dis. 2011;1(2):197-203. doi: 10.3233/JPD-2011-11037.

PMID:
23934921
4.

A prospective study of loss of consciousness in epilepsy using virtual reality driving simulation and other video games.

Yang L, Morland TB, Schmits K, Rawson E, Narasimhan P, Motelow JE, Purcaro MJ, Peng K, Raouf S, Desalvo MN, Oh T, Wilkerson J, Bod J, Srinivasan A, Kurashvili P, Anaya J, Manza P, Danielson N, Ransom CB, Huh L, Elrich S, Padin-Rosado J, Naidu Y, Detyniecki K, Hamid H, Farooque P, Astur R, Xiao B, Duckrow RB, Blumenfeld H.

Epilepsy Behav. 2010 Jul;18(3):238-46. doi: 10.1016/j.yebeh.2010.04.011.

5.

Narcolepsy in Parkinson's disease.

Haq IZ, Naidu Y, Reddy P, Chaudhuri KR.

Expert Rev Neurother. 2010 Jun;10(6):879-84. doi: 10.1586/ern.10.56. Review.

PMID:
20518604
6.

The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire.

Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, Ruessmann A, Odin P, Macphee G, Stocchi F, Ondo W, Sethi K, Schapira AH, Martinez Castrillo JC, Martinez-Martin P.

Mov Disord. 2010 Apr 30;25(6):704-9. doi: 10.1002/mds.22868.

PMID:
20437539
7.

Development and validation of high-throughput liquid chromatography-tandem mass spectrometric method for simultaneous quantification of clopidogrel and its metabolite in human plasma.

Reddy S R, Rao Divi K, Chandiran IS, Jayaveera KN, Naidu YK, Reddy MP.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Feb 1;878(3-4):502-8. doi: 10.1016/j.jchromb.2009.12.026. Epub 2010 Jan 4.

PMID:
20060791
8.

International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.

Martinez-Martin P, Rodriguez-Blazquez C, Abe K, Bhattacharyya KB, Bloem BR, Carod-Artal FJ, Prakash R, Esselink RA, Falup-Pecurariu C, Gallardo M, Mir P, Naidu Y, Nicoletti A, Sethi K, Tsuboi Y, van Hilten JJ, Visser M, Zappia M, Chaudhuri KR.

Neurology. 2009 Nov 10;73(19):1584-91. doi: 10.1212/WNL.0b013e3181c0d416.

PMID:
19901251
9.

Early Parkinson's disease and non-motor issues.

Chaudhuri KR, Naidu Y.

J Neurol. 2008 Sep;255 Suppl 5:33-8. doi: 10.1007/s00415-008-5006-1. Review.

PMID:
18787880
10.

The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, Ondo W, Abe K, Macphee G, Macmahon D, Barone P, Rabey M, Forbes A, Breen K, Tluk S, Naidu Y, Olanow W, Williams AJ, Thomas S, Rye D, Tsuboi Y, Hand A, Schapira AH.

Mov Disord. 2007 Oct 15;22(13):1901-11.

PMID:
17674410
11.

Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients.

Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, MacPhee G, Brown RG, Naidu Y, Clayton L, Abe K, Tsuboi Y, MacMahon D, Barone P, Rabey M, Bonuccelli U, Forbes A, Breen K, Tluk S, Olanow CW, Thomas S, Rye D, Hand A, Williams AJ, Ondo W, Chaudhuri KR.

Mov Disord. 2007 Aug 15;22(11):1623-9.

PMID:
17546669
12.

Transdermal rotigotine: a new non-ergot dopamine agonist for the treatment of Parkinson's disease.

Naidu Y, Chaudhuri KR.

Expert Opin Drug Deliv. 2007 Mar;4(2):111-8. Review.

PMID:
17335409
13.

Expression of the oxytocin and V1a vasopressin receptors in human myometrium in differing physiologic states and following misoprostol administration.

Wing DA, Goharkhay N, Felix JC, Rostamkhani M, Naidu YM, Kovacs BW.

Gynecol Obstet Invest. 2006;62(4):181-5. Epub 2006 May 29.

PMID:
16733363
14.

DBR1 siRNA inhibition of HIV-1 replication.

Ye Y, De Leon J, Yokoyama N, Naidu Y, Camerini D.

Retrovirology. 2005 Oct 18;2:63.

15.

EP3-2 receptor mRNA expression is reduced and EP3-6 receptor mRNA expression is increased in gravid human myometrium.

Wing DA, Goharkhay N, Hanna M, Naidu YM, Kovacs BW, Felix JC.

J Soc Gynecol Investig. 2003 Apr;10(3):124-9.

PMID:
12699873
16.
17.

Aberrant expression of E-cadherin in cervical intraepithelial neoplasia correlates with a false-negative Papanicolaou smear.

Felix JC, Lonky NM, Tamura K, Yu KJ, Naidu Y, Lai CR, Lonky SA.

Am J Obstet Gynecol. 2002 Jun;186(6):1308-14.

PMID:
12066114
18.

The expression of EP3-6 and inducible nitric oxide synthase messenger RNA are correlated in pregnant and misoprostol-treated but not in nongravid or menopausal myometrium.

Goharkhay N, Wing DA, Pan V, McCausland V, Hanna M, Naidu YM, Felix JC.

Am J Obstet Gynecol. 2002 Jun;186(6):1202-6.

PMID:
12066099
20.

Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.

Masood R, Cai J, Zheng T, Smith DL, Naidu Y, Gill PS.

Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):979-84.

21.

Functional significance of donor islet interleukin-1 receptor type 1 (IL-1Rt1) expression in islet transplantation.

Kaufman DB, Naidu Y, Norman JG, Fink G, Rosenfeld D, Lumsden B, Nam E, Abecassis MM, Fryer JP, Stuart FP.

Transplant Proc. 1997 Feb-Mar;29(1-2):772-3. No abstract available.

PMID:
9123521
22.
23.

Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma.

Naidu YM, Rosen EM, Zitnick R, Goldberg I, Park M, Naujokas M, Polverini PJ, Nickoloff BJ.

Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5281-5.

24.

Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma.

Goodman RE, Nestle F, Naidu YM, Green JM, Thompson CB, Nickoloff BJ, Turka LA.

J Immunol. 1994 Jun 1;152(11):5189-98.

PMID:
7910619
25.
26.

Usage of T cell receptor beta-chain variable gene is highly restricted at the site of inflammation in murine autoimmune uveitis.

Rao NA, Naidu YM, Bell R, Lindsey JW, Pararajasegaram G, Sun Y, Steinman L.

J Immunol. 1993 Jun 15;150(12):5716-21.

PMID:
8390540
27.

Recent advances in AIDS-related Kaposi's sarcoma.

Gill PS, Naidu YM, Salahuddin SZ.

Curr Opin Oncol. 1990 Dec;2(6):1161-6. Review. No abstract available.

PMID:
2099846
28.

Significance of premature stop codons in env of simian immunodeficiency virus.

Kodama T, Wooley DP, Naidu YM, Kestler HW 3rd, Daniel MD, Li Y, Desrosiers RC.

J Virol. 1989 Nov;63(11):4709-14.

29.

Influence of DDT and PCBs in rabbits and goats as related to nucleic acid, protein and lipid metabolism.

Chung RA, Williams CS, Naidu YM, Thakore VR.

J Environ Pathol Toxicol Oncol. 1989 May-Jun;9(3):283-302.

PMID:
2509680
30.

Extensive genetic variability of simian immunodeficiency virus from African green monkeys.

Li Y, Naidu YM, Daniel MD, Desrosiers RC.

J Virol. 1989 Apr;63(4):1800-2.

31.

Cellular localization of simian immunodeficiency virus in lymphoid tissues. II. In situ hybridization.

Wyand MS, Ringler DJ, Naidu YM, Mattmuller M, Chalifoux LV, Sehgal PK, Daniel MD, Desrosiers RC, King NW.

Am J Pathol. 1989 Feb;134(2):385-93.

32.

Use of infectious molecular clones of simian immunodeficiency virus for pathogenesis studies.

Kestler HW 3rd, Naidu YN, Kodama T, King NW, Daniel MD, Li Y, Desrosiers RC.

J Med Primatol. 1989;18(3-4):305-9.

PMID:
2760916
33.

Genetic diversity of simian immunodeficiency virus.

Li Y, Naidu Y, Fultz P, Daniel MD, Desrosiers RC.

J Med Primatol. 1989;18(3-4):261-9.

PMID:
2569537
34.

Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac.

Naidu YM, Kestler HW 3rd, Li Y, Butler CV, Silva DP, Schmidt DK, Troup CD, Sehgal PK, Sonigo P, Daniel MD, et al.

J Virol. 1988 Dec;62(12):4691-6.

35.

Simian immunodeficiency virus from African green monkeys.

Daniel MD, Li Y, Naidu YM, Durda PJ, Schmidt DK, Troup CD, Silva DP, MacKey JJ, Kestler HW 3rd, Sehgal PK, et al.

J Virol. 1988 Nov;62(11):4123-8.

36.

Comparison of simian immunodeficiency virus isolates.

Kestler HW 3rd, Li Y, Naidu YM, Butler CV, Ochs MF, Jaenel G, King NW, Daniel MD, Desrosiers RC.

Nature. 1988 Feb 18;331(6157):619-22.

PMID:
2893293
37.

Relationship Between Extracellular Neutral Protease Production and Appearance of Bleb-Like Evaginations in Pseudomonas fragi.

Thompson SS, Naidu YM, Pestka JJ.

J Food Prot. 1985 Dec;48(12):1067-1070. doi: 10.4315/0362-028X-48.12.1067.

PMID:
30939715
38.
39.

Transplacental transmission in bancroftian filariasis.

Rao KR, Venkatanaryana M, Naidu YD, Narasimham MV, Viswanatham R, Rao CK.

Indian J Med Res. 1984 Apr;79:495-6. No abstract available.

PMID:
6386686
40.
41.

Comparative study of thick smear examination and membrane filter technique in parasitological diagnosis of bancroftian filariasis.

Narasimham MV, Naidu YD, Rao CK.

J Commun Dis. 1981 Sep;13(3):204-6. No abstract available.

PMID:
7045200
42.

A five year microbiological study of cholera incidence in twin cities of Hyderabad and Secunderabad during 1971-75.

Subba Rao M, Ramana Rao PV, Ratna K, Sudhakar K, Rajyalakshmi K, Naidu YK.

Indian J Public Health. 1978 Apr-Jun;22(2):182-8. No abstract available.

PMID:
711289

Supplemental Content

Support Center